--- title: "The research enthusiasm for star companies is high, and leading enterprises frequently release positive signals" type: "News" locale: "en" url: "https://longbridge.com/en/news/251259631.md" description: "This week, 125 listed companies disclosed institutional research minutes, with nearly 40% of stocks achieving positive returns. Defu Technology and VGT rose more than 20%, while ChemPartner, DAYANG BIOTECH, ALD, and 7 other stocks rose more than 10%. The median price change of the surveyed stocks was -1.51%" datetime: "2025-08-01T23:31:32.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/251259631.md) - [en](https://longbridge.com/en/news/251259631.md) - [zh-HK](https://longbridge.com/zh-HK/news/251259631.md) --- # The research enthusiasm for star companies is high, and leading enterprises frequently release positive signals According to the Securities Times, Wind data shows that this week, a total of 125 listed companies disclosed institutional research minutes, with nearly 40% of the stocks researched by institutions achieving positive returns. Among them, Defu Technology and VGT saw increases of over 20%, while ChemPartner, DAYANG BIOTECH, ALD, and 7 other stocks rose by more than 10%. The median price change of the researched stocks was -1.51% ### Related Stocks - [300149.CN](https://longbridge.com/en/quote/300149.CN.md) - [003017.CN](https://longbridge.com/en/quote/003017.CN.md) - [300696.CN](https://longbridge.com/en/quote/300696.CN.md) - [301511.CN](https://longbridge.com/en/quote/301511.CN.md) - [300476.CN](https://longbridge.com/en/quote/300476.CN.md) ## Related News & Research - [Should You Be Adding Daewoong Pharmaceutical (KRX:069620) To Your Watchlist Today?](https://longbridge.com/en/news/286824214.md) - [College students boo after a 'new AI system' misses names during graduation ceremony](https://longbridge.com/en/news/286953353.md) - [Totaligent Closes Strategic Acqui-Hire of Aetherium Medical Platform | TGNT Stock News](https://longbridge.com/en/news/287061134.md) - [Elron says Axonius tops $200 million ARR, doubles revenue in two years](https://longbridge.com/en/news/287069566.md) - [Phase 3-ready cancer biotech Parabilis Medicines files for a $100 million IPO](https://longbridge.com/en/news/286972125.md)